导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 28.27% | 29/133 |
| 近一周 | -0.46% | 18/152 |
| 近一月 | -3.70% | 40/152 |
| 近一季 | -5.39% | 28/149 |
| 近半年 | 6.70% | 48/142 |
| 近一年 | 30.82% | 29/133 |
| 近两年 | 61.66% | 8/100 |
| 近三年 | 42.55% | 9/72 |
| 成立以来 | 55.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
15.83% 95/341 |
3.83% 200/349 |
12.72% 122/355 |
- - |
| 2024 | 25.65% 41/330 |
-1.41% 183/280 |
10.97% 18/310 |
17.90% 102/319 |
-2.59% 186/330 |
| 2023 | -12.86% 176/276 |
0.29% 155/205 |
-0.64% 124/230 |
-8.36% 217/262 |
-4.58% 222/276 |
| 2022 | -4.85% 25/202 |
-7.98% 51/153 |
6.46% 49/164 |
-14.76% 97/189 |
13.95% 60/202 |
| 2021 | -12.14% 70/151 |
5.16% 66/312 |
0.71% 212/328 |
-12.01% 235/358 |
-5.71% 80/151 |
| 2020 | -6.27% 62/104 |
-14.10% 183/280 |
4.35% 231/295 |
-7.02% 282/299 |
12.46% 88/305 |
| 2019 | 13.35% 57/89 |
9.84% 126/258 |
1.71% 123/268 |
-5.49% 227/253 |
7.36% 110/266 |
| 2018 | -8.00% 38/80 |
- - |
- - |
- - |
-7.17% 85/241 |
| 2017 | 28.81% 12/69 |
- - |
- - |
- - |
- - |
| 2016 | 8.48% 20/59 |
- - |
- - |
- - |
- - |
| 2015 | -3.25% 24/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2715 | 28.77% |
| 易方达标普生物科技人民币A | 1.7172 | 27.30% |
| 易方达标普生物科技人民币C | 1.6936 | 27.21% |
| 易方达标普生物科技美元汇A | 0.2432 | 27.07% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4590 | 18.72% |
| 广发生物科技指数美元(QDII)A | 0.2081 | 18.51% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3424 | 17.84% |
| 广发生物科技指数人民币(QDII)C | 1.4450 | 17.77% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币C | 1.3639 | 17.05% |
| 广发全球医疗保健美元现汇(QDII)A | 0.3574 | 10.55% |
| 南方恒指ETF VS. 天弘恒生科技指数(QDII)C(012349) |